Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials

AIMS/HYPOTHESIS: This study aimed to evaluate the effect of ertugliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on eGFR and albuminuria (urine albumin/creatinine ratio [UACR]) vs glimepiride or placebo/glimepiride (non-ertugliflozin) over 104 weeks of treatment in participants with ty...

Full description

Saved in:
Bibliographic Details
Published in:Diabetologia
Main Authors: Cherney, David Z. I., Heerspink, Hiddo J. L., Frederich, Robert, Maldonado, Mario, Liu, Jie, Pong, Annpey, Xu, Zhi J., Patel, Shrita, Hickman, Anne, Mancuso, James P., Gantz, Ira, Terra, Steven G.
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7228910/
https://ncbi.nlm.nih.gov/pubmed/32236732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-020-05133-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items